AI-Powered Risk Assessments for Smarter Preventative Care
One Platform. Multiple Diseases. Actionable Insights.
Our Products
Take the guesswork out of disease prevention with AI-driven risk assessments that combine genetic and clinical data for superior accuracy. Our cutting-edge solutions empower clinicians to predict, prevent, and personalize care like never before.
CardioRisk+
Predict disease and cardiovascular risk earlier and more accurately with AI-driven genetic and clinical insights.
CancerRisk+
Assess breast, colon, and prostate cancer risk with AI-driven polygenic risk scoring.
TotalRisk+
Combine monogenic and polygenic testing for the most comprehensive, AI-enhanced cancer risk assessment.
PolyRisk+
Assess full-body genetic risk across eight disease areas with AI-powered polygenic scoring.
How it Works
Easy-to-Use, Interactive Software
Empower Clinicians. Engage Patients. Elevate Care.
OpenDNA’s patented platform seamlessly integrates into clinical workflows, providing AI-powered insights without added complexity.
-
Automated Data Pull
Effortlessly integrates patient data from EMRs. -
Gen AI-Based Decision Support
Provides real-time, actionable insights. -
Interactive Patient Engagement
Empowers clinicians and patients with interactive "what-if" risk modeling scenarios.
Who Can Benefit?
-
Primary Care Physicians (PCPs):
Enhance early detection, risk assessment, and personalized prevention strategies. -
Specialists (Cardiologists, Oncologists, Genetic Counselors):
Improve risk stratification and optimize treatment planning. -
Preventive Health & Wellness Clinics:
Offer personalized, advanced risk assessments for proactive healthcare. -
Executive & Corporate Health Programs:
Enhance screening and prevention for high-performance individuals seeking proactive care. -
Health Systems & Insurers:
Strengthen population health management and risk-based care models.
